COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy

被引：2
|
作者：
Kussmaul, William G., III [1 ]
机构：
[1] 1343 West Baltimore Pike,E-401, Media, PA 19063 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2020年 / 173卷 / 03期
关键词：
D O I：
10.7326/M20-3047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：237 / 238
页数：2
相关论文
共 50 条
  • [1] Re: Is there a difference in the effect between the angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker on the COVID-19?
    Liu, Xiao
    Long, Chuyan
    Xiong, Qinmei
    Chen, Chen
    Ma, Jianyong
    Su, Yuhao
    Hong, Kui
    CLINICAL CARDIOLOGY, 2021, 44 (01) : 7 - 8
  • [2] Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality
    Fosbol, Emil L.
    Butt, Jawad H.
    ostergaard, Lauge
    Andersson, Charlotte
    Selmer, Christian
    Kragholm, Kristian
    Schou, Morten
    Phelps, Matthew
    Gislason, Gunnar H.
    Gerds, Thomas A.
    Torp-Pedersen, Christian
    Kober, Lars
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (02): : 168 - 177
  • [3] Effects of combination therapy of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker
    Idrizi, A
    Gjata, M
    Barbullushi, M
    Koroshi, A
    Tase, M
    Sadiku, E
    Hoti, K
    JOURNAL OF HYPERTENSION, 2005, 23 : S398 - S398
  • [4] Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation A Nationwide Cohort Study
    Hsieh, Yu-Cheng
    Hung, Chen-Ying
    Li, Cheng-Hung
    Liao, Ying-Chieh
    Huang, Jin-Long
    Lin, Ching-Heng
    Wu, Tsu-Juey
    MEDICINE, 2016, 95 (20)
  • [5] A CLINICAL EVALUATION OF HYPERKALAEMIA IN PATIENTS WITH RENAL IMPAIRMENT ON COMBINATION THERAPY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN-RECEPTOR BLOCKER
    Goh, T. H.
    Tan, S. C.
    Fook-Chong, S. M. C.
    Wong, K. S.
    Chan, C. M.
    NEPHROLOGY, 2005, 10 : A139 - A139
  • [6] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers benefits outweigh the risks in COVID-19 hypertensive patients
    Ateya, Areej Mohamed
    Sabri, Nagwa A.
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (04) : 1873 - 1874
  • [7] Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Use and COVID-19: Time to Change Practice or Keep Gathering Data?
    de Feria, Alejandro
    Ortega-Legaspi, Juan M.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (09) : 2457 - 2458
  • [8] ANTIPROTEINURIC AND RENOPROTECTIVE EFFECTS OF COMBINATION THERAPY WITH AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND AN ANGIOTENSIN RECEPTOR BLOCKER
    Sadiku, Edita
    Idrizi, Alma
    Gjata, Margarita
    Barbullushi, Myftar
    Hoti, Klit
    Tase, Mihal
    Koroshi, Alketa
    NEPHROLOGY, 2005, 10 : A136 - A136
  • [9] Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure
    Struckman, DR
    Rivey, MP
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 242 - 248
  • [10] Paradoxical pressor response with angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Sabitha, P.
    Adhikari, Prabha M.
    AUSTRALASIAN MEDICAL JOURNAL, 2011, 4 (07): : 364 - +
12345